The ECRAID-Prime #adaptiveplatformtrial is a first-of-its-kind multinational study in community care using decentralised trial elements. Read the key learnings & experiences on meaningful #patientinvolvement to strengthen clinical trials in #publichealth emergencies. 👉🏼 www.ecraid.eu/news/ecraid-...

Ecraid and @esicm.bsky.social announce a strategic partnership to strengthen #ICU research, education, & pandemic preparedness across Europe. Together we’ll expand networks, drive joint studies, co-develop training on infections, sepsis, AMR & crisis preparedness. 👉🏽More info: bit.ly/esicm-ecraid

Today on #KangarooCareAwarenessDay 🦘, we’re proud to support @pentafoundation.bsky.social in raising awareness of kangaroo care. Ecraid is proud to contribute to the #NeoDeco study, exploring how optimised kangaroo care may help reduce #NeonatalInfections and #Sepsis in preterm infants in #NICUs. 🩺

Emerging threats like #Hantavirus require a warm-based, unified response. Ecraid works at the heart of the #BEREADY partnership to connect clinical sites with global stakeholders and national authorities. Together with our partners, we stand ready. #PandemicPreparedness #InfectiousDiseases

🙌🏽 Pleased to share that the #ECRAIDPrime LTX-109 study has achieved its recruitment target! 🧪Read more about this EU-funded trial and Phase 2A study on the LTX-109 compound, developed by Pharma Holdings on lnkd.in/eHR28vr9.

Join this 5th edition of our postgraduate course 👉 bit.ly/48jUgdg The programme is not limited to ID specialists; we welcome clinical researchers from all disciplines, epidemiologists, and public health professionals seeking to elevate their study design and evidence generation skills.

Our April newsletter is live! 🔬 Highlights from ESCMID Global 2026 🎓 PG course in Verona now open for registration 🤝🏽 New global partnerships driving innovation in clinical research Stay informed—subscribe for monthly updates: bit.ly/EcraidNewsAp... #InfectiousDiseases #ClinicalResearch #Education

We were pleased to host a successful #SNAPTrial Investigator Meeting at #ESCMIDGlobal2026. Last Tuesday’s session brought together Chief Investigators from across Europe, as well as our Coordinating Chief Investigators from Australia, who provided a valuable global perspective & progress updates.

Wrapping up day 1 at #ESCMIDGlobal2026 not a full stop, just a comma. Great discussions with colleagues & partners, all focused on advancing #InfectiousDiseases research & preparedness. Thanks to everyone who joined our sessions & stopped by. Strong start, round two tomorrow! See you at booth F21!

🌟 #Milestone - The #ECRAIDPrime NONS and saline nasal spray study has concluded, marking the completion of a key phase in evaluating treatments for #respiratoryinfections in the community, and proof-of-concept for accelerating clinical research response to outbreaks. 👉🏼 ecraid.eu/news/ecraid-...

Last Call to register! 🔔 Join the PrIMAVeRa Stakeholder Meeting & Live hashtag#AMR Dashboard Demo in Munich! 📅 Sunday, 19 April 2026 🕛 12:00 – 15:00 (CEST) 📍 H4 Hotel München Messe (5 mins’ walk from ESCMID venue) Limited spots available! 📩 Interested? Send an email to [email protected].

Ecraid has joined the BEAM Alliance, reinforcing our commitment to tackling antimicrobial resistance. By contributing our clinical research expertise and network, we aim to better connect innovation with real-world needs & help shape future AMR solutions in Europe. 👉🏽Read more: bit.ly/BeamAlliance

📣 Arjan van Manen joins us as Head of Business Development. With 20+ years in clinical strategy, he’s focused on closing the gap between clinical need & investment risk. 🤝🏽 Understanding challenges to deliver data-driven, tailored solutions. 📍At ESCMID? Connect with him! 🔗https://bit.ly/ArjanEcraid

📝 Have insights on ethical review procedures for cohort studies? Participate in this survey (15–20 min) to help improve the efficiency of ethical review processes for cohort studies during public health emergencies. www.id-care.net/post/share-y...

📣 Our March newsletter is out! 🔬 Join us at #ESCMIDGlobal2026 in Munich (Booth F21) 🎓 5th Young Investigator Workshop – 19 April, 09:30 CEST 🏥 ECRAID-Prime trial advances patient-centric research Plus new publications & collaborations. 👉🏽Subscribe now: mailchi.mp/ecraid/newsl...

Join the Young Investigator Workshop at #ESCMIDGlobal 2026 for practical insights and science you can actually use! Early-career investigators are driven to deliver meaningful research, but navigating the “how” isn’t always straightforward. 📍 Room 2 (ICM Ground Floor) 👉 bit.ly/4uKdN0r

Looking ahead to #ESCMIDGlobal 2026 in Munich, we’re reflecting on the energy & collaboration from Vienna last year. Great to connect with so many experts & partners advancing ID research. Excited to continue these conversations in Munich. Will you be there? Visit us at booth F21: bit.ly/474r0qy

📢Ecraid has joined the WHO Global Clinical Trials Forum. This milestone boosts our mission to advance high-quality research, strengthen global collaboration, and improve trial readiness, data sharing, and patient outcomes worldwide. Read more: bit.ly/418YDEh #GlobalHealth @whowpro.bsky.social

A recent article published in Contemporary Clinical Trial Communications evaluates the considerations raised during the regulatory & ethics review of five ID #PlatformTrials: #ECRAIDPrime, #RECLAIM, #REMAPCAP, #RECOVERY, and #SNAP. Explore the full article here bit.ly/4v0qSCH #TrialInnovation

📍Visit us at booth #F21 at #ESCMID Global 2026 in Munich! Innovation in ID requires strong partnerships. 🔬At Ecraid we're committed to building & growing collaborations across Europe to strengthen clinical research & tackle AMR. Meet our team & explore how we can work together: bit.ly/474r0qy

Two new #ECRAIDBase publications available! 🫁 The first provides a detailed narrative of the POS-VAP study. 📊 The second asks how do we measure knowledge, attitudes, & practices around biomedical data reuse? Explore the papers bit.ly/4beBA0z #ClinicalTrials #VAP #DataScience #CriticalCare

Will you be at #ESCMIDGlobal 2026 in Munich? Visit Ecraid at booth F21. As AMR and emerging infections continue to challenge healthcare systems, collaboration across academia, clinical networks & industry is essential. Interested in connecting? Book a meeting: bit.ly/474r0qy #InfectiousDiseases

The world of #ClinicalResearch is evolving fast - are you ready to grow with it? Join our 5th Young Investigator Workshop at #ESCMIDGlobal2026. A dedicated space for early-career researchers to gain practical, real-world insights you won't find in textbooks: bit.ly/4uKdN0r @escmid.bsky.social

At the AMR Conference in Basel, Ecraid announced a new partnership with @incate.bsky.social. Together we’re connecting clinical research & translational innovation to accelerate antimicrobial development & strengthen the pipeline against #AMR. Read how we combine our strengths: bit.ly/INCATE-Ecraid

Last Friday, @christophercbutler.bsky.social presented at the #RethinkingClinicalTrials webinar (hosted by @dcrinews.bsky.social and @pctcollaboratory.bsky.social). He highlighted pre-pandemic studies & how ECRAID-Prime & ECRAID-Base are strengthening #Europe’s response to future health threats.

🫱🏼‍🫲🏻 We're proud to present the #PrIMAVeRaProject and our #perpetualobervationalstudies at the 7th @amr-accelerator.bsky.social Cross-Project Meeting held in Basel yesterday. We look forward to seeing everyone again at the PrIMAVeRa stakeholder meeting at #ESCMID2026! @elskesieswerda.bsky.social

What if, in the next infectious disease outbreak, patients are: 🤒 Too sick to travel? 🦠 Unable to visit clinics & traditional research sites? 🏔️ Living in remote or underserved areas? The #ECRAIDPrime trial demonstrates that research does not need to stop. Trials can come to the patient.

New collaboration! We’re proud to announce that Ecraid has officially partnered with INCATE. We will play a key role in supporting, educating & guiding early-stage translational projects, strengthening their path toward successful development of new treatment modalities to combat #AMR.

See you at #ESCMIDGlobal2026 in Munich! 🇩🇪 Find us in the Exhibition Hall (Booth F21), and throughout the scientific programme. Our committed colleagues will present Ecraid-driven science in posters, presentations and talks during the congress. More details soon! @escmid.bsky.social

📢 Meet us at the AMR Conference in Basel! Our CEO @lenniederde.bsky.social & Head of BD Arjan van Manen will be attending. Ecraid is looking forward to discuss future collaborations with you! 📅 Book a meeting with us via the PartneringOne platform: lnkd.in/edKBRYf

Ecraid’s second newsletter of the year is out! Discover the latest updates, studies, publications & upcoming events! Inside this edition: 🔍Highlights from the Ecraid Foundation Science Meeting 🚀The launch of BE READY NOW And much more... 👉🏽Stay informed, subscribe now: bit.ly/EcraidNewsFe...

📢 Meet us at the AMR Conference in Basel! Our CEO @lenniederde.bsky.social & Head of BD Arjan van Manen will be attending. Ecraid is looking forward to discuss future collaborations with you! 📅 Book a meeting with us via the PartneringOne platform: lnkd.in/edKBRYf

🇪🇺 Our recent CoMeCT project Sustainability Workshop discussed the future development of the project’s coordination activities and its role in #BEREADY project to strengthen #clinicalresearch readiness for #publichealth emergencies. Read more on 👉🏽 www.ecraid.eu/news/coordin...

Lennie Derde speaks about #PandemicPreparedness in @horizoneu.bsky.social Magazine She explains the importance of a permanent clinical research infrastructure across Europe to tackle emerging #InfectiousDiseases & #AntimicrobialResistance projects.research-and-innovation.ec.europa.eu/en/horizon-m...

The BE READY NOW European Partnership is live! 🚀 Ecraid is supporting this initiative by building 'ever-warm' research networks & FAIR data protocols, ensuring Europe is ready to respond to threats with unprecedented speed. 🔗 Full details bit.ly/463tpBe #PandemicPreparedness #ClinicalResearch

Today in #InternationalEducationDay Ecraid is more than an organisation focused on clinical research. It is a place where young and early-career talent and experienced experts – from both academia and industry – connect to collaborate and learn. Explore our Education Page: ecraid.eu/education

📣 The first site has been activated in the PIPELINE-RSV International trial & is now open for recruitment at St George's University Hospitals NHS Foundation Trust in London! Congratulations to everyone involved in reaching this important milestone! #RSV #Vaccination #MonoclonalAntibodies #mAbs

🚨 Last Call: Ecraid Foundation Science Meeting! Today is your final chance to register for this academic event bringing together leading experts from academia, industry, and the public sector. Can’t attend this time? You can still stay connected! Subscribe to our newsletter: bit.ly/EcraidJan26

📢 Ecraid Foundation Science Meeting: registration deadline extended! Join industry leaders, researchers, clinicians & policy experts to discuss cutting-edge science & collaboration in infectious diseases and clinical research. Accredited by NVMM (11 points) and ABIC www.eventbrite.nl/e/ecraid-fou...

Read this research letter on the re-emergence of M. pneumoniae 👉 publications.ersnet.org/content/erjo... This unexpected surge emphasises the need for continued attention to respiratory #pathogen dynamics and their impact on #PatientCare and #PublicHealth responses. @europeanrespsoc.bsky.social

📢 Programme Update: Meet our Speakers! We’ve added new speakers to the Ecraid Foundation Science Meeting - each track now features a detailed programme. Featured speakers include: Pontus Naucler (Karolinska Institute) Kristina Rudd (Pittsburgh University) & industry leaders. 👉🏼 Register: bit.ly/EFSM

🤧 The EU-funded #ECRAIDPrime trial has randomised its first 3 remote patients in the #UK this flu season — launching a patient-centric approach to expand access and community participation. This is a big step for infectious disease trials in #PrimaryCare and #Europe. 🎉 Congrats to the Oxford team!

Europe’s first #adaptiveplatformtrial for #COVID19 and COVID-like illness in the community launched its third treatment arm, marking an important step forward in Europe's pandemic preparedness. Read about this pioneering trial on www.ecraid.eu/news/primary...

3 years on, Ecraid is firmly embedded in Europe’s infectious diseases research ecosystem. In this interview with Prof. Sir @peterhorby.bsky.social from the Pandemic Sciences Institute, Oxford, he discusses Ecraid’s clinical trial infrastructure & future challenges. www.ecraid.eu/articles/eur...

🚨 The countdown is on for the Ecraid Foundation Science Meeting 2026! Join us for high-impact scientific exchange and collaborative networking. 🥼 Access to infectious disease experts 🏆 Accreditation by ABIC and NVMM Don’t miss your chance to register: www.eventbrite.nl/e/ecraid-fou...

🎧Recording available! Tune into this webinar in collaboration with @europeanrespsoc.bsky.social on #PandemicPreparedness 👇 channel.ersnet.org/media-114951...

As we close out 2025, we look back on a truly landmark year for Ecraid: one defined by growth, collaboration, and impact. Thank you to our partners, collaborators, sites, investigators, and team members for your commitment and trust. Happy holidays, and all the best for the year ahead 🌟

🎉 Amazing milestones reached in three of our perpetual observational studies (POS)! We are tremendously proud of ALL the site teams behind these studies, for making it happen as 2025 comes to an end - a great way to wrap up the year! Thank you! ecraid.eu/ecraid-base/...

Announcing Module 2 of the Ecraid x @ESCMID online course on Biomedical Data & Sample Governance: 'How to design your data governance framework' in collaboration with CoMeCT, IDDO, CERCLE, @who.int and @tghn-news.bsky.social 🎧👉 www.escmid.org/education/ed... #DataGovernance #EpidemicPreparedness

📩Our final newsletter of 2025 is out! As we close 2025, we also say farewell to our CEO, @marcbonten.bsky.social. We are proud of what we have achieved together over the years & look ahead with confidence to 2026, welcoming @lenniederde.bsky.social onboard! Read more & subscribe: bit.ly/Dec25Ecraid